Category: Emerging Medicine
Staying on top of emerging medicine is vital for providing the best care to patients and has multiple benefits for physicians. Staying on top of emerging medicine is vital for providing the best care to patients and has multiple benefits for physicians.
One of the several noteworthy trials presented at the virtual ESC Congress was the EAST-AFNET 4NET 4 trial, which was published concurrently in the New England Journal of Medicine.
A group of Italian researchers recently hypothesized that it is actually the endothelium that is being targeted by the COVID-19 virus.
COVID-19 does not always fit into the pattern of respiratory illness. While initially unexpected, clinicians and researchers are learning more each day that COVID-19 infection wears many disguises. In some victims, it clearly does not make its initial appearance as a respiratory virus.
Atrial Fibrillation: Scope of the Problem The prevalence of atrial fibrillation (AF) in the United States is estimated to rise from ≈5.2 million in 2010 to 12.1 million in 2030.…
Partnering with patients to assess their risk for cardiovascular disease can be a challenge. Developing a plan of care to manage hypertension is individualized; incorporating patient buy-in sets the stage…
The 2019 ACC/AHA Guideline on the Prevention of Cardiovascular Disease includes management of diabetes mellitus as a key takeaway for cardiologists caring for patients with this comorbidity.
Challenge your knowledge of this patient population with K2P and Dr. Biykem Bozkurt, MD, PhD’s series on evidence-based management of heart failure.
The relationship between diabetes and cardiovascular disease are interdependent, requiring a deep understanding of the management of diabetes mellitus.
A December 18, 2019 case report in JACC underscores the complex and varied challenges for patients with a paravalvular leak.